Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

Published:2016-06-20 Issue:9 Volume:18 Page:907-915
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Khunti K.¹,Alsifri S.²,Aronson R.³,Cigrovski Berković M.⁴,Enters‐Weijnen C.⁵,Forsén T.⁶,Galstyan G.⁷,Geelhoed‐Duijvestijn P.⁸,Goldfracht M.⁹¹⁰,Gydesen H.¹¹,Kapur R.¹¹,Lalic N.¹²,Ludvik B.¹³,Moberg E.¹⁴,Pedersen‐Bjergaard U.¹⁵,Ramachandran A.¹⁶,

Affiliation:

1. Diabetes Research Centre University of Leicester Leicester UK

2. Al Hada Military Hospital Taif Saudi Arabia

3. LMC Diabetes and Endocrinology Toronto Canada

4. University Hospital ‘Sestre Milosrdnice’ Zagreb Croatia

5. Julius Clinical/Julius Center UMC Utrecht Zeist the Netherlands

6. Department of General Practice and Primary Health Care University of Helsinki Helsinki Finland

7. Endocrinology Research Center Moscow Russian Federation

8. Medical Center Haaglanden The Hague the Netherlands

9. Clalit Health Services Tel Aviv Israel

10. The Technion Haifa Israel

11. Novo Nordisk A/S Søborg Denmark

12. Faculty of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia University of Belgrade Belgrade Serbia

13. Rudolfstiftung Hospital and Medical University of Vienna Vienna Austria

14. Karolinska Institutet Stockholm Sweden

15. Nordsjællands Hospital Hillerød Hillerød Denmark

16. India Diabetes Research Foundation and Dr A Ramachandran's Diabetes Hospitals Chennai India

Funder

National Institute for Health Research

Novo Nordisk

Bristol-Myers Squibb

AstraZeneca

Sanofi

Boehringer Ingelheim

Medtronic

Takeda Pharmaceuticals U.S.A.

Medpace

GlaxoSmithKline

Pfizer

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12689

Reference27 articles.

1. Dosing Irregularities and Self-Treated Hypoglycemia in Type 2 Diabetes: Results from the Canadian Cohort of an International Survey of Patients and Healthcare Professionals

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

4. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

5. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New advances in type 1 diabetes;BMJ;2024-01-26

2. Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review;Frontiers in Pharmacology;2024-01-23

3. Hypoglycaemia in Diabetes;Textbook of Diabetes;2024-01-12

4. A cross-sectional questionnaire study: impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia;2024-01-12

5. Acute emergencies in diabetes;BIDE' s Diabetes Desk Book;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3